Proliferation of human keratinocytes and cocultured human keratinocytes and fibroblasts in three-dimensional fibrin constructs

Tissue Engineering - Part A

Volumn 17, Issue 3-4, 2011, Pages 429-437

  Sese, Nadjah ^a   Cole, Marietta ^a   Tawil, Bill ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIALS; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION (PROCESS); FIBROBLASTS; OPTIMIZATION; STEM CELLS;

CELL TYPES; FIBRINOGEN CONCENTRATION; GROWTH FACTOR; HUMAN KERATINOCYTES; IN-VITRO; KERATINOCYTES; NORMAL HUMAN DERMAL FIBROBLASTS; THREE-DIMENSIONAL (3D);

THREE DIMENSIONAL;

BIOMATERIAL; FIBRIN;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; COCULTURE; CYTOLOGY; DRUG EFFECT; FIBROBLAST; HUMAN; KERATINOCYTE; MATERIALS TESTING; METHODOLOGY; PHYSIOLOGY; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FIBRIN; FIBROBLASTS; HUMANS; KERATINOCYTES; MATERIALS TESTING; TISSUE ENGINEERING;

EID: 79551525353     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0113     Document Type: Article

References (21)

1. Tuan, T.L., Song, A., Chang, S., Younai, S., and Nimni, M.E. In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Exp Cell Res 223, 127, 1996.
2. Wechselberger, G., Schoeller, T., Stenzl, A., Ninkovic, M., Lille, S., and Russell, R.C. Fibrin glue as a delivery vehicle for autologous urothelial cell transplantation onto a prefabricated pouch. J Urol 160, 583, 1998.
3. Horch, R.E., Bannasch, H., and Stark, G.B. Transplantation of cultured autologous keratinocytes in fibrin sealant biomatrix to resurface chronic wounds. Transplant Proc 33, 642, 2001.
4. Perka, C., Schultz, O., Spitzer, R.S., Lindenhayn, K., Bur-mester, G.R., and Sittinger, M. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 21, 1145, 2000.
5. Schense, J.C., Bloch, J., Aebischer, P., and Hubbell, J.A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat Biotechnol 18, 415, 2000.
6. Van Griensven, M., Zeichen, J., Tschernig, T., Seekamp, A., and Pape, H.-C. A modified method to culture human osteoblasts from bone tissue specimens using fibrin glue. Exp and Toxic Path 54, 25, 2002.
7. Tawil, B. Fibrin and Its Applications. Review. An Introduction to Biomaterials, Chapter 7. Guelcher, S.A., and Hollinger, J.O., eds. Boca Raton, FL: CRC Taylor & Francis, 2005, pp. 105-120.
8. Duong, H., Wu, B., and Tawil, B. Fibrin matrices in tissue engineering. In: Natural-based Polymers for Biomedical Applications. Boca Raton, FL: CRC Taylor & Francis, 2008, pp. 533-543.
9. Duong, H., Wu, B., and Tawil, B. Modulation of 3-dimen-sional fibrin matrix stiffness by intrinsic fibrinogen-thrombin compositions and by extrinsic cellular activity. Tissue Eng 15, 1865, 2009.
10. Cox, S., Cole, M., and Tawil, N. The behavior of human dermal fibroblasts in 3 dimensional fibrin clots: dependence on the fibrinogen and thrombin concentration. Tissue Eng 10, 942, 2004.
11. Ho, W., Tawil, B., Dunn, J.C., and Wu, B.M. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng 12, 1, 2006.
12. Catelas, I., Sese, N., Wu, B., Dunn, J., Helgerson, S., and Tawil, B. Human mesenchymal stem cells proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng 12, 1, 2006.
13. Mana, M., Cole, M., Cox, S., and Tawil, B. Human U937 monocyte behavior and protein expression on various formulations of three-dimensional fibrin clots. Wound Repair Regen 14, 72, 2006.
14. R as a delivery vehicle for active macrophage activator lipoprotein-2 Peptide: in vitro studies. Wound Repair Regen 15, 521, 2007.
15. Mogford, J., Tawil, B., and Mustoe, T. Fibrin sealant combined with fibroblasts and PDGF enhance wound healing in excisional wounds. Wound Repair Regen 17, 405, 2009.
16. Auger, F.A., Lacroix, D., and Germain, L. Skin substitutes and wound healing. Skin Pharmacol Physiol 22, 94, 2009.
17. Cox, S., Cole, M., Mankarious, S., and Tawil, N.J. The effect of tranexamic acid incorporated in fibrin sealant clots on cell behavior of neuronal and non-neuronal cells. J Neuronal Research 72, 734, 2003.
18. Boyce, S., Michel, S., Reichert, U., Shroot, B., and Schmidt, R. Reconstructed skin from cultured human keratinocytes and fibroblasts on a collagen-glycosaminoglycan biopolymer substrate. Skin Pharmacol 3, 136, 1990.
19. Dai, N.-T., Yeh, M.-K., Chiang, C.-H., Chen, K.-C., Liu, T.-H., Feng, A.-C., Chao, L.-L., Shih, C.-M., Sytwu, H.-K., Chen, S.-L., Chen, T.-M., and Adams, E.F. Human single-donor composite skin substitutes based on collagen and poly-caprolactone copolymer. Biochem Biophys Res Commun 386, 21, 2009.
20. Sun, T., Haycock, J., and MacNeil, S. In situ image analysis of interactions between normal human keratinocytes and fi-broblasts cultured in three-dimensional fibrin gels. Biomaterials 27, 3459, 2006.
21. Deiters, U., Barsig, J., Tawil, N., and Mü hlradt, P. The macrophage activating lipopeptide MALP-2 accelerates wound healing in diabetic mice. Exp Dermatol 13, 731, 2004.